The stock is struggling badly, and if things don't improve in short order, Eli Lilly will be on track for its worst ...

In May, it announced it would acquire SiteOne Therapeutics, a drugmaker with a promising investigational medicine for pain.

The stock market indexes had big weekly gains despite some daily swings. Palantir and Shopify were among huge earnings movers.